Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 204 participants.

Also called NCT05096442

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 204 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05096442
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05096442. Randomized; single masking; primary purpose treatment. Start 2021-09-30 (actual); primary completion 2023-06-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
Intervention (Device)
GENOSS® DCB
Intervention (Device)
SeQuent® Please NEO
Lead sponsor
Genoss Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05096442
Content hash
01a3e1e93c3ffa1ebe9266bf81eade9e8b490f09993b97fdc49eb61c2aaf4b9a